MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars) _ Parkinson's Disease
Hillhurst Biopharmaceuticals
Organization & Developments: Hillhurst Biopharmaceuticals
Parents
Hillhurst Biopharmaceuticals
Children
*Address challenges of inhaled gases by liquid delivery of therapeutic gases to ensure accurate dosing
*Hillhurst’s lead product, HBI-002, developed with the GLASS™ platform, enables oral liquid delivery of low doses of the medical gas carbon monoxide.
*Liquid therapeutic gases to treat patients with sickle cell disease
*Manages acute pain, and transplant surgery
*Platform enables oral delivery of low-dose carbon monoxide
*This delivery method may address key medical issues of diabetic retinopathy, sickle cell disease vaso-occlusive crisis, and Parkinson’s disease.
2025: Funders back Hillhurst Bio Phase 2a trials for Parkinson's therapeutic
Jumps
Finance & Acquisition: Hillhurst Biopharmaceuticals
Key People: Hillhurst Biopharmaceuticals